NCT01190865View on ClinicalTrials.gov

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Normal Female Volunteers

Interventions

BIOLOGICAL

HP802-247

One dose of HP802-247 consisting off 260 mL containing keratinocytes and fibroblasts totaling 5.0 x 10.6 cells per mL, plus fibrin.

Trial Locations (1)

Unknown

RCTS, Inc., Irving

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Healthpoint

INDUSTRY